(Q59289153)
Statements
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy (English)
Marshall E
Dürig J
Watanabe K
Howell A
Miles D
Kiernan J
Griffiths A
Towlson K
DeTakats P
Testa NG
Dougal M
Hunter MG
Wood LM
Czaplewski LG
Millar A
Dexter TM
1 September 1998